Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

Fort Dodge Laboratories Inc: ProHeart 6 Injectable for Dogs Recalled for Failing Dissolution Stability

Agency Publication Date: July 20, 2004
Share:
Sign in to monitor this recall

Summary

Fort Dodge Laboratories Inc. has recalled approximately 7,390 packs of ProHeart 6 (moxidectin) Sustained Release Injectable for Dogs. This veterinary medication is being recalled because the moxidectin microspheres failed dissolution testing during a 6-month stability check. This failure means the medication may not release properly or provide the intended long-term protection for dogs as expected. Owners who had their dogs treated with this specific medication should contact their veterinarian for guidance.

Risk

The failing dissolution results indicate the medication may not release the active ingredient (moxidectin) into the dog's system at the required rate, potentially leading to reduced effectiveness in preventing heartworm disease or other targeted conditions.

What You Should Do

  1. Check your pet's medical records or contact your veterinarian to see if your dog received Fort Dodge ProHeart 6 (moxidectin) Sustained Release Injectable for Dogs from NDC 0856-3670-20.
  2. Identify if the product used was from the 5-unit packs containing 20-ml moxidectin microsphere and vehicle vials (NADA 141-189).
  3. Contact your veterinarian or pharmacist immediately to discuss if your pet requires a re-evaluation of their heartworm prevention plan due to this recall.
  4. If you are a veterinarian or wholesaler with remaining stock of these vials, stop using them immediately and secure the product for return.
  5. Return any unused product to the place of purchase for a refund and contact Fort Dodge Animal Health at their office in Fort Dodge, Iowa, for further instructions on returning the defective lots.
  6. For additional questions or to report adverse events, contact the FDA Center for Veterinary Medicine at 1-888-FDA-VETS.

Your Remedy Options

💰Full Refund

Veterinary drug return and refund process

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Fort Dodge ProHeart 6 (moxidectin) Sustained Release Injectable for Dogs (17 ml Sterile Vehicle / 10% w/w microspheres)
Model:
NADA 141-189
NDC 0856-3670-20
Recall #: V-130-4

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 28875
Status: Active
Manufacturer: Fort Dodge Laboratories Inc
Sold By: retail accounts; wholesale accounts; veterinary clinics
Manufactured In: United States
Units Affected: 7,390/5-unit packs
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response